{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:51:07Z","timestamp":1781877067407,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["34789"],"award-info":[{"award-number":["34789"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["E120503"],"award-info":[{"award-number":["E120503"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04138-y","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:48:28Z","timestamp":1768319308000},"page":"2638-2653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The\u00a0miRNA-4330\/ABCG2 axis overcomes drug resistance and cancer progression\u00a0in\u00a0both\u00a0ER-positive and\u00a0ER-negative resistant breast cancer cells"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1526-9603","authenticated-orcid":false,"given":"Shaymaa M. M.","family":"Yahya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-431X","authenticated-orcid":false,"given":"Sohair M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba K.","family":"Nabih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9766-3593","authenticated-orcid":false,"given":"Shimaa Ibrahim Abdelmenym","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada H.","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"1","key":"4138_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024 [published correction appears in CA Cancer J Clin. 2024 Mar-Apr;74(2):203. doi:10.3322\/caac.21830.]. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"4138_CR2","unstructured":"WHO, Breast cancer.https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer. 26, March, 2021."},{"key":"4138_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286-287","author":"Sonkin","year":"2024","unstructured":"Sonkin, Thomas, Teicher. Cancer treatments: past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324. https:\/\/doi.org\/10.1016\/j.cancergen.2024.06.002.","journal-title":"Cancer Genet"},{"issue":"5","key":"4138_CR4","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1007\/s13277-015-4426-7","volume":"37","author":"SM Yahya","year":"2016","unstructured":"Yahya SM, Hamed AR, Emara M, Soltan MM, Abd-Ellatef GE, Abdelnasser SM. Differential effects of c-myc and ABCB1 silencing on reversing drug resistance in HepG2\/Dox cells. Tumor Biol. 2016;37(5):5925\u201332. https:\/\/doi.org\/10.1007\/s13277-015-4426-7.","journal-title":"Tumor Biol"},{"key":"4138_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-60761-416-6_4","volume":"596","author":"Gillet","year":"2010","unstructured":"Gillet, Gottesman. Mechanisms of multidrug resistance in cancer. Methods Mol Biol. 2010;596:47\u201376. https:\/\/doi.org\/10.1007\/978-1-60761-416-6_4.","journal-title":"Methods Mol Biol"},{"key":"4138_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00044-017-2079-3","volume":"27","author":"AR Hamed","year":"2018","unstructured":"Hamed AR, Emara M, Soltan MM, Yahya SMM, Nabih HK, Elsayed GH. Investigating the role of miRNA-98 and miRNA-214 in chemoresistance of HepG2\/Dox cells: studying their effects on predicted ABC transporters targets. Med Chem Res. 2018;27:531\u20137.","journal-title":"Med Chem Res"},{"issue":"9","key":"4138_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093233","volume":"21","author":"K Bukowski","year":"2020","unstructured":"Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020;21(9):3233. https:\/\/doi.org\/10.3390\/ijms21093233.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4138_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1059-5","volume":"38","author":"L Zhang","year":"2019","unstructured":"Zhang L, Liao Y, Tang L. MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer. J Exp Clin Cancer Res. 2019;38(1):53. https:\/\/doi.org\/10.1186\/s13046-019-1059-5.","journal-title":"J Exp Clin Cancer Res"},{"key":"4138_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00626","volume":"10","author":"M Cui","year":"2019","unstructured":"Cui M, Wang H, Yao X, et al. Circulating microRNAs in cancer: potential and challenge. Front Genet. 2019;10:626. https:\/\/doi.org\/10.3389\/fgene.2019.00626.","journal-title":"Front Genet"},{"issue":"3","key":"4138_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031234","volume":"23","author":"M Guz","year":"2022","unstructured":"Guz M, Jeleniewicz W, Cybulski M. An insight into miR-1290: an oncogenic miRNA with diagnostic potential. Int J Mol Sci. 2022;23(3):1234. https:\/\/doi.org\/10.3390\/ijms23031234.","journal-title":"Int J Mol Sci"},{"key":"4138_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cancergen.2022.11.002","volume":"270-271","author":"Fonseca","year":"2023","unstructured":"Fonseca, Gonz\u00e1lez-Giraldo, Santos, Aristiz\u00e1bal-Pach\u00f3n. The hsa-miR-516a-5p and hsa-miR-516b-5p microRNAs reduce the migration and invasion on T98G glioblastoma cell line. Cancer Genet. 2023;270\u2013271:12\u201321. https:\/\/doi.org\/10.1016\/j.cancergen.2022.11.002.","journal-title":"Cancer Genet"},{"issue":"6","key":"4138_CR12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.neuron.2016.05.005","volume":"90","author":"N Rani","year":"2016","unstructured":"Rani N, Nowakowski TJ, Zhou H, et al. A primate lncRNA mediates Notch signaling during neuronal development by sequestering miRNA. Neuron. 2016;90(6):1174\u201388. https:\/\/doi.org\/10.1016\/j.neuron.2016.05.005.","journal-title":"Neuron"},{"key":"4138_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278-279","author":"Liu","year":"2023","unstructured":"Liu, Tang. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u2013279:91\u2013103. https:\/\/doi.org\/10.1016\/j.cancergen.2023.10.001.","journal-title":"Cancer Genet"},{"issue":"1","key":"4138_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-01018-5-5","volume":"19","author":"Z Xu","year":"2024","unstructured":"Xu Z, Rasteh AM, Dong A, Wang P, Liu H. Identification of molecular targets of Hypericum perforatum in blood for major depressive disorder: a machine-learning pharmacological study. Chin Med. 2024;19(1):141. https:\/\/doi.org\/10.1186\/s13020-024-01018-5-5.","journal-title":"Chin Med"},{"key":"4138_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6702424","volume":"2016","author":"Krisnamurti","year":"2016","unstructured":"Krisnamurti, Louisa, Anggraeni, Wanandi. Drug efflux transporters are overexpressed in short-term tamoxifen-induced MCF7 breast cancer cells. Adv Pharmacol Sci. 2016;2016:6702424. https:\/\/doi.org\/10.1155\/2016\/6702424.","journal-title":"Adv Pharmacol Sci"},{"issue":"2","key":"4138_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s12253-018-0502-9","volume":"25","author":"Salem","year":"2019","unstructured":"Salem, Hamed, Fayez, Nour Eldeen. Non-target genes regulate miRNAs-mediated migration steering of colorectal carcinoma. Pathol Oncol Res. 2019;25(2):559\u201366. https:\/\/doi.org\/10.1007\/s12253-018-0502-9.","journal-title":"Pathol Oncol Res"},{"issue":"8","key":"4138_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182870","volume":"12","author":"R Punia","year":"2017","unstructured":"Punia R, Raina K, Agarwal R, Singh RP. Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells. PLoS ONE. 2017;12(8):e0182870. https:\/\/doi.org\/10.1371\/journal.pone.0182870.","journal-title":"PLoS ONE"},{"key":"4138_CR18","doi-asserted-by":"publisher","unstructured":"Cinatl J Jr, Wass M N, & Michaelis M. (2024). Drug-resistant cell lines in cancer.\u00a0Nature communications,\u00a015(1), 8253. https:\/\/doi.org\/10.1038\/s41467-024-52441-z","DOI":"10.1038\/s41467-024-52441-z"},{"key":"4138_CR19","doi-asserted-by":"publisher","unstructured":"Wong RS, Ong RJ, Lim JS. Immune checkpoint inhibitors in breast cancer: development, mechanisms of resistance and potential management strategies.\u00a0Cancer Drug Resist. 2023;6(4):768\u2013787. Published 2023 Nov 17. https:\/\/doi.org\/10.20517\/cdr.2023.58","DOI":"10.20517\/cdr.2023.58"},{"key":"4138_CR20","unstructured":"Zhang XL, Shi HJ, Wang JP, Tang HS, Cui SZ. MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting Hedgehog\/smoothened.\u00a0Int J Clin Exp Pathol. 2015;8 (6):6397\u20136406. Published 2015 Jun 1."},{"issue":"6","key":"4138_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063199","volume":"22","author":"J He","year":"2021","unstructured":"He J, Fortunati E, Liu DX, Li Y. Pleiotropic roles of ABC transporters in breast cancer. Int J Mol Sci. 2021;22(6):3199. https:\/\/doi.org\/10.3390\/ijms22063199.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4138_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1705-z","volume":"10","author":"XG Zhao","year":"2019","unstructured":"Zhao XG, Hu JY, Tang J, et al. Mir-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer. Cell Death Dis. 2019;10(7):479. https:\/\/doi.org\/10.1038\/s41419-019-1705-z.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4138_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06434-4","volume":"9","author":"A Yokoi","year":"2018","unstructured":"Yokoi A, Matsuzaki J, Yamamoto Y, et al. Integrated extracellular microRNA profiling for ovarian cancer screening. Nat Commun. 2018;9(1):4319. https:\/\/doi.org\/10.1038\/s41467-018-06434-4.","journal-title":"Nat Commun"},{"issue":"12","key":"4138_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13123028","volume":"13","author":"GI Lambrou","year":"2021","unstructured":"Lambrou GI, Zaravinos A, Braoudaki M. Co-deregulated miRNA signatures in childhood central nervous system tumors: in search for common tumor miRNA-related mechanics. Cancers (Basel). 2021;13(12):3028. https:\/\/doi.org\/10.3390\/cancers13123028.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"4138_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102204","volume":"9","author":"M BeLow","year":"2020","unstructured":"BeLow M, Osipo C. Notch signaling in breast cancer: a role in drug resistance. Cells. 2020;9(10):2204. https:\/\/doi.org\/10.3390\/cells9102204.","journal-title":"Cells"},{"issue":"7","key":"4138_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.biopha.2013.04.005","volume":"67","author":"Januchowski","year":"2013","unstructured":"Januchowski, Wojtowicz, Zabel. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance. Biomed Pharmacother. 2013;67(7):669\u201380. https:\/\/doi.org\/10.1016\/j.biopha.2013.04.005.","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"4138_CR27","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s11010-023-04667-6","volume":"478","author":"A Nimisha","year":"2023","unstructured":"Nimisha A, Saluja SS, Sharma AK, et al. Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance. Mol Cell Biochem. 2023;478(10):2379\u201394. https:\/\/doi.org\/10.1007\/s11010-023-04667-6.","journal-title":"Mol Cell Biochem."},{"issue":"11","key":"4138_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116296","volume":"23","author":"A Chimento","year":"2022","unstructured":"Chimento A, D\u2019Amico M, Pezzi V, De Amicis F. Notch signaling in breast tumor microenvironment as mediator of drug resistance. Int J Mol Sci. 2022;23(11):6296. https:\/\/doi.org\/10.3390\/ijms23116296.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4138_CR29","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1158\/1535-7163.MCT-14-0228","volume":"14","author":"D'Angelo","year":"2015","unstructured":"D\u2019Angelo, Ouzounova, Davis, et al. Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity. Mol Cancer Ther. 2015;14(3):779\u201387. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0228.","journal-title":"Mol Cancer Ther"},{"issue":"38","key":"4138_CR30","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1038\/onc.2008.226","volume":"27","author":"P Rizzo","year":"2008","unstructured":"Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of Notch signaling in cancer. Oncogene. 2008;27(38):5124\u201331. https:\/\/doi.org\/10.1038\/onc.2008.226.","journal-title":"Oncogene"},{"issue":"10","key":"4138_CR31","first-page":"3853","volume":"30","author":"Grudzien","year":"2010","unstructured":"Grudzien, Lo, Albain, et al. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Anticancer Res. 2010;30(10):3853\u201367.","journal-title":"Anticancer Res"},{"issue":"1","key":"4138_CR32","doi-asserted-by":"publisher","DOI":"10.7243\/2050-120X-2-12","volume":"2","author":"P-Y Chuang","year":"2023","unstructured":"Chuang P-Y, Huang C, Huang H-C. The use of a combination of tamoxifen and doxorubicin synergistically to induce cell cycle arrest in BT483 cells by down-regulating CDK1, CDK2 and cyclin D expression. J Pharm Technol Drug Res. 2023;2(1):12. https:\/\/doi.org\/10.7243\/2050-120X-2-12.","journal-title":"J Pharm Technol Drug Res"},{"issue":"10","key":"4138_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105384","volume":"22","author":"L Jaromi","year":"2021","unstructured":"Jaromi L, Csongei V, Vesel M, et al. KRAS and EGFR mutations differentially alter ABC drug transporter expression in cisplatin-resistant non-small cell lung cancer. Int J Mol Sci. 2021;22(10):5384. https:\/\/doi.org\/10.3390\/ijms22105384.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4138_CR34","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/ijc.24796","volume":"126","author":"Z Chen","year":"2010","unstructured":"Chen Z, Liu F, Ren Q, Zhao Q, Ren H, Lu S, et al. Suppression of ABCG2 inhibits cancer cell proliferation. Int J Cancer. 2010;126(4):841\u201351. https:\/\/doi.org\/10.1002\/ijc.24796.","journal-title":"Int J Cancer"},{"issue":"3","key":"4138_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4062\/biomolther.2017.042","volume":"26","author":"Q Liu","year":"2018","unstructured":"Liu Q, Cao Y, Zhou P, Gui S, Wu X, Xia Y, et al. Panduratin A inhibits cell proliferation by inducing G0\/G1 phase cell cycle arrest and induces apoptosis in breast cancer cells. Biomol Ther (Seoul). 2018;26(3):328\u201334. https:\/\/doi.org\/10.4062\/biomolther.2017.042.","journal-title":"Biomol Ther (Seoul)"},{"issue":"12","key":"4138_CR36","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1158\/0008-5472.CAN-10-0269","volume":"70","author":"YC Wang","year":"2010","unstructured":"Wang YC, He F, Feng F, Liu X-W, Dong G-Y, Qin H-Y, et al. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res. 2010;70(12):4840\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-0269.","journal-title":"Cancer Res"},{"key":"4138_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00652","volume":"9","author":"T Palaga","year":"2018","unstructured":"Palaga T, Wongchana W, Kueanjinda P. Notch signaling in macrophages in the context of cancer immunity. Front Immunol. 2018;9:652. https:\/\/doi.org\/10.3389\/fimmu.2018.00652.","journal-title":"Front Immunol"},{"issue":"1","key":"4138_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10549-017-4394-2","volume":"166","author":"H Liu","year":"2017","unstructured":"Liu H, Wang J, Zhang M, et al. Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients. Breast Cancer Res Treat. 2017;166(1):95\u2013107. https:\/\/doi.org\/10.1007\/s10549-017-4394-2.","journal-title":"Breast Cancer Res Treat"},{"issue":"6186","key":"4138_CR39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1252510","volume":"344","author":"RA Franklin","year":"2014","unstructured":"Franklin RA, Liao W, Sarkar A, et al. The cellular and molecular origin of tumor-associated macrophages. Science. 2014;344(6186):921\u20135. https:\/\/doi.org\/10.1126\/science.1252510.","journal-title":"Science"},{"issue":"4","key":"4138_CR40","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","volume":"34","author":"O Meurette","year":"2018","unstructured":"Meurette O, Mehlen P. Notch signaling in the tumor microenvironment. Cancer Cell. 2018;34(4):536\u201348. https:\/\/doi.org\/10.1016\/j.ccell.2018.07.009.","journal-title":"Cancer Cell"},{"key":"4138_CR41","doi-asserted-by":"crossref","unstructured":"Li R, Huang Y, Liu H, Dilger J P, Lin j. Comparing volatile and intravenous anesthetics in a mouse model of breast cancer metastasis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting; 2018 Apr 14\u201318; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 2162.","DOI":"10.1158\/1538-7445.AM2018-2162"},{"key":"4138_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148829","volume":"931","author":"SMM Yahya","year":"2024","unstructured":"Yahya SMM, Elsayed GH. The role of MiRNA-34 family in different signaling pathways and its therapeutic options. Gene. 2024;931:148829. https:\/\/doi.org\/10.1016\/j.gene.2024.148829.","journal-title":"Gene"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04138-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04138-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04138-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:57:57Z","timestamp":1781873877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04138-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["4138"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04138-y","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to include the supplementary file.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that there are no conflicts of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}